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1. Introduction
  Psoriasis is a chronic inflammation induced by 
various stimuli, such as inherit factors, cell apoptosis, 
immunological factors, inflammation and neurotransmitters, 
etc. The pathogenesis is still unclear. It is reported 
that the morbidity of psoriasis is about 3% in Asian. Its 
physiopathological mechanism includes proliferation 
of epidermic cells and activation of immunological 
system. There are 4 types of psoriasis: psoriasis vulgaris, 
psoriasis pustulosa, psoriasis arfhropathica and psoriatic 
erythroderma, and psoriasis vulgaris is the commonest[1]. 
Chemokines comprises of 50 kinds of low molecular weight 
polypeptide. It can induce leukocytes such as lymphocyte, 
monocyte, neutrophil, etc to aggregate in inflammatory 
area. It mediates infiltration, location and activation of 
immunological cells. Besides, it can induce formation of 
lymphoid follicle from lymphocyte. Chemokines plays a 
important key in development of autoimmune diseases[2]. 
Macrophage inflammatory protein-1 (MIP-1) 毩, MIP-1
毬 and monocyte chemoattractant protein-1 (MCP-1) are 
important chemokines. It is proved that they participate in 
various autoimmune diseases[3]. This study aims to explore 
the correlation between MIP-1毩, MIP-1毬 and MCP-1 
psoriasis area and severity index (PASI), and to observe 
the effect of oral administration of acitretin and external 
application of tacrolimus on expression of MIP-1毩, MIP-1
毬 and MCP-1 in patients of psoriasis vulgaris.
2. Materials and methods
2.1. Objective
  A total of 50 cases of psoriasis vulgaris visiting between 
Objective: To detect the expression level of macrophage inflammatory protein-1 (MIP-1)毩, 
MIP-1毬 and monocyte chemoattractant protein-1 (MCP-1) in with psoriasis vulgaris and explore 
the role in the pathogenesis of psoriasis vulgaris. Methods: The level of MIP-1毩,MIP-1毬 
and MCP-1 in peripheral blood from 50 patients with psoriasis vulgaris and 50 normal controls 
were measured by enzyme linked immunosorbent assay. The correlation with psoriasis area and 
severity index (PASI) was analyzed. The level of MIP-1毩, MIP-1毬 and MCP-1 was compared 
between psoriasis vulgaris patients at active stage and resting stage. And the change in MIP-1毩, 
MIP-1毬 and MCP-1 before and after therapy was also observed. Results: The content of MIP-1毩,
MIP-1毬 and MCP-1 in patients with psoriasis vulgaris was (1342.78依210.30), (175.28依28.18) and 
(266.86依32.75) ng/L, respectively, significantly higher than those in control group (P<0.05). The 
expression level of MIP-1毩, MIP-1毬 and MCP-1 in peripheral blood of patients with psoriasis 
vulgaris was positively correlated with PASI (P<0.01). After acitretin therapy, expression level 
of MIP-1毩, MIP-1毬 and MCP-1 in peripheral blood of patients with psoriasis vulgaris was 
significantly decreased. Conclusions: Chemokine factor MIP-1毩, MIP-1毬 and MCP-1 may be 
involved in the pathogenesis of psoriasis vulgaris.
Yong-Jiang Dai et al./Asian Pacific Journal of Tropical Medicine (2014)582-584 583
June 2012 and December 2013 were selected, including 
29 males and 21 females, aged 20-50 years old, with 
average age as (29.60依8.29) years. Patients had no history of 
corticoid, immunosuppressor etc in 4 weeks, and all were 
in accord with diagnosis of psoriasis vulgaris. Patients with 
other autoimmune diseases, systematical chronic diseases, 
incompetent hepatorenal function, administration of 
glucocorticoids, immunosuppressor, macrolides in 1 month 
were excluded. They comprised of 35 cases at active stage 
and 15 cases at resting stage. PASI score was performed. 
Another 50 healthy persons were selected, including 30 
males and 20 females, aged 25-53 years old, with average 
age as (30.14依8.52) years. There was no significant difference 
in gender and age between two groups. 
2.2. Sampling
  Five mL venous blood of patients with confirmed 
psoriasis vulgaris and without any treatment was extracted, 
centrifugated to obtain supematant. It was preserved 
in liquid nitrogen. Serum of experiment group was also 
collected 4 weeks after treatment.  
2.3. Reagent
  Mouse anti-human monoclonal antibody, ELISA of MIP-1
毩, MIP-1毬 and MCP-1 were purchased from R&D System. 
Enzyme mark detector type Elx800 was from USA BIO-TEK 
Company.
2.4. Methods
  MIP-1毩, MIP-1毬 and MCP-1 was detected by ELISA 
strictly according to instruction. 
2.5. Medical invention 
  Patients in experimental group had external application 
of tacrolimus and oral administration of acitretin (Huabang 
Pharma Co Ltd, Chongqing) after lunch, 30 mg/d for 4 
weeks. Side effect was observed. The administration 
was discontinued as soon as skin allergy or neurological 
symptoms occurred. 
2.6. PASI score
  To guarantee the uniformity and reliability, the PASI score 
was performed by the same physician.
2.7. Statistical analysis
  All data were analyzed by SPSS19.0. The difference in 
MIP-1毩, MIP-1毬 and MCP-1 between two groups, and the 
difference between those before and after treatment were 
analyzed by t test and 氈
2 test. The correlation between PASI 
and MIP-1毩, MIP-1毬 and MCP-1 was analyzed by Person 
test.
3. Results 
3.1. PASI score  
  The PASI score was 18.25依5.56 in 50 patients of psoriasis 
vulgaris before treatment.
3.2. MIP-1毩, MIP-1毬 and MCP-1 level between 
experimental group and control group
  The result showed that MIP-1毩, MIP-1毬 and MCP-1 
were significantly higher in experimental group than those 
of control group (P<0.01) (Table 1).
Table 1
MIP-1毩, MIP-1毬 and MCP-1 level between experimental group 
and control group.
Group MIP-1毩 (ng/L) MIP-1毬 (ng/L) MCP-1 (ng/L)
Experimental 
group 
1 342.78依210.30 175.28依28.18 266.86依32.75
Control group   756.82依166.62   93.75依19.27 158.90依25.36
t value 15.442 16.887 18.430
P value <0.001 <0.001 <0.001
3.2. MIP-1毩, MIP-1毬 and MCP-1 level between patients 
at active stage and resting stage
  The result showed that MIP-1毩, MIP-1毬 and MCP-1 
level of patients at active stage were significantly higher 
than those of patients at resting stage (P<0.01) (Table 2).
Table 2
MIP-1毩, MIP-1毬 and MCP-1 level between patients at 
active stage and resting stage.
Group MIP-1毩 (ng/L) MIP-1毬 (ng/L) MCP-1 (ng/L)
Experimental 
group 
1 389.26依225.23 182.56依28.85 275.47依33.54
Control group 1 195.35依208.67 160.84依27.55 242.60依32.04
t value 2.849 2.472 3.217
P value 0.006 4 0.017 1 0.002 3
3.3. MIP-1毩, MIP-1毬 and MCP-1 level before and after 
medical intervention 
  Four weeks after treatment, MIP-1毩, MIP-1毬 and MCP-1 
were significantly decreased (P<0.01), but the levels were 
still significantly higher than those in control group (P<0.01) 
(Table 3).
Table 3
MIP-1毩, MIP-1毬 and MCP-1 level before and after 
medical intervention.
Group MIP-1毩 (ng/L) MIP-1毬 (ng/L) MCP-1 (ng/L)
Before
treatment 
1 342.78依210.30 175.28依28.18 266.86依32.75
After
treatment 
  1 025.65依180.53▲   131.75依22.35▲   195.67依28.91▲
▲P<0.01 vs. before treatment.
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3.4. Correlation between PASI and MIP-1毩, MIP-1毬 and 
MCP-1 level
  Person analysis showed that MIP-1毩 (r=0.652, P<0.01), 
MIP-1毬 (r=0.436, P=0.0031) and MCP-1 (r=0.585, P<0.01) 
were positively correlated with PASI score. 
Beside no side effect occurred in experimental group.
4. Discussion
  Chemokines includes 50 kinds of low molecular weight 
polypeptide which comprise of 60-100 amino acids. The 
front end of molecular structure is composed of 4 kinds of 
cysteine. They are divided into 4 subfamilies according to 
the existence of amino acid between the first two cysteines: 
C, CC, CXC and C3XC4 (X means amino acid)[4,5]. MIP-1毩,
MIP-1毬 and MCP-1 mentioned in our study all belong to 
CC subfamily, which can induce chemotaxis of T cell and 
monocytes, activate and assemble monocyte-macrophage 
to participate in immune-mediated inflammation process[6]. 
Chemokines and their receptors play important role in 
migration of leukocyte under both normal and ill condition. 
They can induce directed migration of lymphocytes, 
monocytes and along with concentration gradient of 
chemokine. Besides, they also take part in various 
physiological regulation of tissues and cells, and play a key 
role in development of many diseases[7,8]. 
  Many researches showed obvious infiltration of 
lymphocytes and monocytes in skin lesion of psoriasis 
patients, especially infiltration of T lymphocytes in dermis, 
which is important pathological character of psoriasis. There 
are various immunological factors such as IL-8, IL-10, IL-12,
TNF-毩, INF-毭 etc in serum of skin lesion, which 
indicate that T cell-mediated immune reaction is important 
mechanism for development of psoriasis[9]. Ekman et al[10] 
reported that expression of CSCL9 and CXCL10 mRNA in 
some patients are significantly higher than those of healthy 
persons. It may be because of activation of STAT1, NF-
kappa B, JAK2 and MEK/ERK pathway, which induce 
keratinocytes to produce CSCL9 and CXCL10. 
  This study shows that expression of MIP-1毩, MIP-1毬 
and MCP-1 in psoriasis vulgaris patients are higher than 
those of healthy people, and it is positively correlated 
with PASI score. It may be because during repair duration, 
various damage factors stimulate the secretion of MIP-1
毩, MIP-1毬 and MCP-1. It causes directed migration of 
responsive T lymphocyte to tissue of skin lesion, then leads 
to immunological inflammation, which induced skin lesion. 
In this study it is found for the first time that 4 weeks after 
external application of tacrolimus and oral administration 
of acitretin, the levesl of MIP-1毩, MIP-1毬 and MCP-1 are 
significantly decreased. Besides, levels of MIP-1毩, MIP-1
毬 and MCP-1 of patients at active stage are significantly 
higher than those of patients at resting stage. It indicates 
that MIP-1毩, MIP-1毬 and MCP-1 may participate in 
pathogenesis of psoriasis vulgaris, and expressions of MIP-1
毩, MIP-1毬 and MCP-1 are associated with its development 
and prognosis. Furthermore, levels of MIP-1毩, MIP-1毬 
and MCP-1 are significantly increased in peripheral blood of 
psoriasis vulgaris patients, and intervention with tacrolimus 
and acitretin can significantly reduce the expression level. It 
may provide new pathway for treatment of psoriasis vulgaris. 
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